Natco Pharma's shares tumble after steep earnings decline amid export challenges and plans for Rs 2,000 crore fundraising

Natco Pharma’s shares fell following a 57% drop in June-quarter profits driven by weaker lenalidomide sales, with the company planning to raise up to Rs 2,000 crore to counteract ongoing export pressures and earnings volatility. Natco Pharma’s shares fell in…













